MM-146: IONA-MM: A Prospective, Non-Interventional, Multinational, Observational Study with Isatuximab in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Clinical Lymphoma Myeloma and Leukemia（2020）
关键词
phase 3,isatuximab,CD38,multiple myeloma,clinical practice,MM
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要